Showing results (291-300 of 344) with videos related to
Sort By:
Pageof 35
Circulation. Population Health and Outcomes|July 2, 2026
Safety and Feasibility of Moderate-Intensity Home-Based Guided Exercise in Aortic Dissection Survivors in the United States: A Multicenter Randomized Controlled TrialDipika Bhatia, Nikhil Erabelli, Kayla House, et al.The Journal of Experimental Medicine|September 22, 1998
APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growthM Hahne, T Kataoka, M Schröter, et al.The New England Journal of Medicine|February 14, 2009
Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantationGero Hütter, Daniel Nowak, Maximilian Mossner, et al.Current Biology : CB|December 23, 1999
The COP9/signalosome complex is conserved in fission yeast and has a role in S phaseK E Mundt, J Porte, J M Murray, et al.Blood|February 7, 2002
Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemiasAdrian F Gombart, Wolf-K Hofmann, Seiji Kawano, et al.Nature|July 10, 1997
Inhibition of death receptor signals by cellular FLIPM Irmler, M Thome, M Hahne, et al.Leukemia Research|July 9, 2011
Clinical management of gastrointestinal disturbances in patients with myelodysplastic syndromes receiving iron chelation treatment with deferasiroxFlorian Nolte, Emanuele Angelucci, Photis Beris, et al.Blood Cancer Journal|July 26, 2012
Antileukemic activity of the HSP70 inhibitor pifithrin-μ in acute leukemiaM Kaiser, A Kühnl, J Reins, et al.Journal of Cancer Research and Clinical Oncology|January 7, 2014
Expression of transketolase-like gene 1 (TKTL1) depends on disease phase in patients with chronic myeloid leukaemia (CML)M Philipp, J Schwaab, C T Dietz, et al.Leukemia|January 30, 2014
MDR1 expression predicts outcome of Ph+ chronic phase CML patients on second-line nilotinib therapy after imatinib failureM Agrawal, B Hanfstein, P Erben, et al.Pageof 35